OPGN logo

OpGen (OPGN) Company Overview

Profile

Full Name:

OpGen, Inc.

Sector:

Healthcare

Country:

United States

IPO:

May 5, 2015

Indexes:

Not included

Description:

OpGen (OPGN) is a biotechnology company focused on developing innovative solutions for infectious disease management. They use advanced genomic technologies to improve diagnostics, enhance antibiotic stewardship, and support personalized medicine, aiming to combat antibiotic resistance and improve patient outcomes in healthcare settings.

Key Details

Price

$0.99

Annual Revenue

$3.42 M(+31.10% YoY)

Annual EPS

-$41.47(+72.84% YoY)

Annual ROE

282.56%

Beta

-0.05

Events Calendar

Earnings

Next earnings date:

Jul 8, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

Mar 29, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 20, 2024

Analyst ratings

Recent major analysts updates

Aug 14, 23 HC Wainwright & Co.
Neutral
Jul 20, 23 HC Wainwright & Co.
Buy
Jun 26, 23 HC Wainwright & Co.
Buy
Jun 21, 23 HC Wainwright & Co.
Buy
May 16, 23 HC Wainwright & Co.
Buy
May 13, 22 HC Wainwright & Co.
Buy
Mar 2, 21 Alliance Global Partners
Buy
Nov 25, 20 Rodman & Renshaw
Buy
Jun 29, 16 Rodman & Renshaw
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for OpGen?
  • Does OpGen pay dividends?
  • What sector is OpGen in?
  • What industry is OpGen in?
  • What country is OpGen based in?
  • When did OpGen go public?
  • Is OpGen in the S&P 500?
  • Is OpGen in the NASDAQ 100?
  • Is OpGen in the Dow Jones?
  • When was OpGen's last earnings report?
  • When does OpGen report earnings?
  • Should I buy OpGen stock now?

What is the ticker symbol for OpGen?

The ticker symbol for OpGen is NASDAQ:OPGN

Does OpGen pay dividends?

No, OpGen does not pay dividends

What sector is OpGen in?

OpGen is in the Healthcare sector

What industry is OpGen in?

OpGen is in the Medical Devices industry

What country is OpGen based in?

OpGen is headquartered in United States

When did OpGen go public?

OpGen's initial public offering (IPO) was on May 5, 2015

Is OpGen in the S&P 500?

No, OpGen is not included in the S&P 500 index

Is OpGen in the NASDAQ 100?

No, OpGen is not included in the NASDAQ 100 index

Is OpGen in the Dow Jones?

No, OpGen is not included in the Dow Jones index

When was OpGen's last earnings report?

OpGen's most recent earnings report was on Nov 15, 2024

When does OpGen report earnings?

The next expected earnings date for OpGen is Jul 8, 2025

Should I buy OpGen stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions